Back

Titan Partners Group and GSR Launch Litecoin Treasury for MEI Pharma

MEI Pharma raises $100 million to establish a Litecoin strategic reserve, with Charlie Lee joining the board to oversee the initiative.

LTC

Summary

MEI Pharma has successfully completed a $100 million private placement, selling 29,239,767 shares at $3.42 each, with plans to establish a Litecoin strategic reserve. Charlie Lee, Litecoin's founder and a lead investor in this placement, has been appointed to the board, while GSR will act as the digital asset advisor overseeing the reserve strategy.

Terms & Concepts
  • Litecoin treasury: A dedicated fund aimed at managing and utilizing Litecoin for strategic investments and initiatives.
  • Private investment in public equity (PIPE): The buying of shares of publicly traded stock at a price below the current market value per share, used to raise capital.
  • GSR: A global leader in digital asset trading and liquidity solutions, partnering with companies to manage cryptocurrency investments.